News Results
There are 921,323 News Results
May 16, 2018
Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck
Jul 25, 2018
SANTA CLARA, Calif., July 25, 2018 /PRNewswire-PRWeb/ -- The CTO Forum, a premier organization for senior technology and business leaders, today announced its featured keynote speakers for the CTO Forum's...
Feb 22, 2019
Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today reported financial results for the fourth quarter and full year ended December 31,...
May 30, 2019
AIRPORT CITY, Israel, May 30, 2019 /PRNewswire/ --
Jun 26, 2019
SCOTCH PLAINS, N.J., June 26, 2019 /PRNewswire-PRWeb/ -- All chiropractors listed below have submitted an application and have been reviewed and approved by NJ Top Docs within the last 12...
Aug 14, 2019
DUBLIN, Aug. 14, 2019 /PRNewswire/ -- The "Digital Transformation 2019: 5G, AI, Big Data Analytics, Blockchain, Cloud and Mobile Edge Computing, Connected and Wearable Devices, Cybersecurity, Digital Twins and Teleoperation,...
Sep 26, 2019
China Finance Online Reports Second Quarter and First Six Months of 2019 Unaudited Financial Results
BEIJING, Sept. 26, 2019 /PRNewswire/ -- China Finance Online Co. Limited ("China Finance Online", or the "Company", "we", "us" or "our") (NASDAQ GS: JRJC), a leading web-based financial services company...
Dec 26, 2019
China Finance Online Reports Third Quarter and First Nine Months of 2019 Unaudited Financial Results
BEIJING, Dec. 26, 2019 /PRNewswire/ -- China Finance Online Co. Limited ("China Finance Online," or the "Company," "we," "us" or "our") (NASDAQ GS: JRJC), a leading web-based financial services company...
Mar 28, 2024
-- TOTAL REVENUE OF $247.6 MILLION FOR THE YEAR ENDED 2023 VS $219.3 MILLION IN 2022, AN INCREASE OF 13% -- HOSPITAL DIVISION OPERATING INCOME OF $36.3 MILLION FOR YEAR...
May 9, 2024
-- Cash, cash equivalents, marketable securities and restricted cash totaled approximately $287.6 million on March 31, 2024, which excludes the net proceeds of approximately $247.8 million from Biohaven's public offering...
